Abbott paid $1.24 billion for the remaining 83.1 percent of AMO’s stock. As a final step of the acquisition, Abbott will form a short-form merger as soon as is practical. The remaining AMO stockholders will receive $22 per share as a result of the merger.
Read the Abbott news release regarding the AMO acquisition.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.